Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.5479 USD
−95.90 M USD
6.22 M USD
145.00 M
About Precigen, Inc.
Sector
Industry
CEO
Helen Sabzevari
Website
Headquarters
Germantown
Founded
1998
FIGI
BBG000QL8VH9
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PGEN is 0.9388 USD — it has decreased by −0.03% in the past 24 hours. Watch Precigen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Precigen, Inc. stocks are traded under the ticker PGEN.
PGEN stock has fallen by −1.89% compared to the previous week, the month change is a −2.62% fall, over the last year Precigen, Inc. has showed a −17.65% decrease.
We've gathered analysts' opinions on Precigen, Inc. future price: according to them, PGEN price has a max estimate of 7.00 USD and a min estimate of 4.00 USD. Watch PGEN chart and read a more detailed Precigen, Inc. stock forecast: see what analysts think of Precigen, Inc. and suggest that you do with its stocks.
PGEN reached its all-time high on Aug 6, 2015 with the price of 68.7840 USD, and its all-time low was 0.7739 USD and was reached on Nov 19, 2024. View more price dynamics on PGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PGEN stock is 6.18% volatile and has beta coefficient of 2.68. Track Precigen, Inc. stock price on the chart and check out the list of the most volatile stocks — is Precigen, Inc. there?
Today Precigen, Inc. has the market capitalization of 264.34 M, it has increased by 10.10% over the last week.
Yes, you can track Precigen, Inc. financials in yearly and quarterly reports right on TradingView.
Precigen, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PGEN earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.09 USD resulting in a −4.34% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Precigen, Inc. earnings.
Precigen, Inc. revenue for the last quarter amounts to 953.00 K USD, despite the estimated figure of 931.40 K USD. In the next quarter, revenue is expected to reach 1.63 M USD.
PGEN net income for the last quarter is −23.98 M USD, while the quarter before that showed −58.79 M USD of net income which accounts for 59.22% change. Track more Precigen, Inc. financial stats to get the full picture.
No, PGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 202.00 employees. See our rating of the largest employees — is Precigen, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Precigen, Inc. EBITDA is −89.88 M USD, and current EBITDA margin is −1.32 K%. See more stats in Precigen, Inc. financial statements.
Like other stocks, PGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Precigen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Precigen, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Precigen, Inc. stock shows the sell signal. See more of Precigen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.